NCT05270863

Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia

Multicenter, Double-Masked, Randomized, Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF Topical Ophthalmic Solution With Emmetropic Phakic and Pseudophakic Presbyopia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 182 (actual)
• Sponsor: Visus Therapeutics · Academic / Other
• Sex: All
• Age: 45 Years – 80 Years
• Healthy volunteers: Accepted

Summary

Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

Detailed description

Multicenter, Double-Masked, Randomized, Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF Topical Ophthalmic Solution With Emmetropic Phakic and Pseudophakic Presbyopia

Conditions

• Presbyopia

Interventions

Type	Name	Description
DRUG	BRIMOCHOL™ PF	A single drop in each eye at a visit.
DRUG	Carbachol PF	A single drop in each eye at a visit.
DRUG	Brimonidine tartrate	A single drop in each eye at a visit.

Timeline

• Start date: 2022-03-30
• Primary completion: 2023-03-17
• Completion: 2023-04-10
• First posted: 2022-03-08
• Last updated: 2024-10-15
• Results posted: 2024-09-05

Locations

15 sites across 1 country: United States

Regulatory

• FDA-regulated drug study